Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.44 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.96.
Market Cap
8.44T
Revenue
4.59T
Profits
201.19B
PE Ratio
41.96
Profit Margin
4.38%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.73% | 2,696,819 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 574.10B | 0.63% | 8,344,709 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 397.44B | -0.21% | 4,133,992 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.03B | -1.34% | 6,503,881 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 294.13B | -0.43% | 10,295,010 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 279.76B | -2.44% | 2,129,533 | 60.44B |
| 7 | NVS | Novartis AG | 273.10B | -0.67% | 1,436,830 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 194.01B | 1.47% | 16,532,316 | 50.57B |
| 9 | AMGN | Amgen Inc. | 182.28B | -1.98% | 2,152,511 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 179.14B | -2.43% | 2,050,834 | 45.20B |
| 11 | ABT | Abbott Laboratories | 155.32B | -2.28% | 11,895,827 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 150.83B | -3.20% | 10,151,890 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 145.92B | -3.42% | 1,998,464 | 10.58B |
| 14 | PFE | Pfizer Inc. | 145.91B | -0.39% | 30,251,167 | 63.32B |
| 15 | DHR | Danaher Corporation | 129.97B | -2.54% | 3,214,981 | 24.78B |
| 16 | CVS | CVS Health Corporation | 125.07B | 0.99% | 7,408,403 | 405.62B |
| 17 | SYK | Stryker Corporation | 118.40B | -1.65% | 1,374,480 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 113.54B | -1.56% | 8,144,028 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.59B | -2.26% | 660,763 | 12.22B |
| 20 | SNY | Sanofi | 105.41B | -2.59% | 4,027,115 | 54.60B |
| 21 | MDT | Medtronic plc | 103.03B | -2.11% | 7,001,047 | 36.36B |
| 22 | GSK | GSK plc | 102.76B | -0.16% | 5,075,873 | 43.29B |
| 23 | MCK | McKesson Corporation | 95.01B | 0.79% | 637,554 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 87.86B | -4.68% | 1,880,461 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 82.82B | -0.42% | 1,919,354 | 76.39B |
| 26 | CI | The Cigna Group | 78.25B | 0.27% | 1,472,280 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 71.85B | -1.27% | 22,669,860 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 61.21B | -2.36% | 815,446 | 14.92B |
| 29 | ARGX | argenx SE | 54.82B | -2.47% | 349,271 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.72B | 0.60% | 776,941 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 50.66B | 1.71% | 3,359,724 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 49.92B | -0.25% | 2,416,808 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 49.51B | -1.78% | 4,537,659 | 6.30B |
| 34 | MDLN | Medline Inc. | 48.00B | 1.47% | 9,245,147 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.93B | -3.79% | 435,313 | 4.45B |
| 36 | HUM | Humana Inc. | 43.76B | 0.35% | 960,211 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 40.72B | -2.80% | 1,747,928 | 22.23B |
| 38 | HLN | Haleon plc | 40.13B | -0.44% | 13,280,362 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.10B | -2.53% | 3,856,527 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.88B | -2.17% | 927,325 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 37.17B | -2.85% | 1,990,760 | 7.23B |
| 42 | WAT | Waters Corporation | 35.66B | -2.15% | 408,188 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 34.08B | -1.11% | 7,063,737 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.80B | -2.64% | 1,230,718 | 10.63B |
| 45 | CNC | Centene Corporation | 32.26B | -1.31% | 5,852,113 | 178.33B |
| 46 | RPRX | Royalty Pharma plc | 31.39B | -2.00% | 1,829,427 | 2.44B |
| 47 | NTRA | Natera, Inc. | 31.01B | -2.84% | 1,025,480 | 2.50B |
| 48 | RVMD | Revolution Medicines, Inc. | 30.65B | -3.58% | 3,281,305 | - |
| 49 | IQV | IQVIA Holdings Inc. | 30.40B | -2.19% | 1,205,837 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 29.31B | -1.70% | 232,245 | 5.70B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.00B | -3.41% | 3,026,327 | 20.98B |
| 52 | DXCM | DexCom, Inc. | 28.85B | -4.37% | 5,037,728 | 4.82B |
| 53 | BIIB | Biogen Inc. | 28.68B | -2.44% | 1,071,082 | 9.94B |
| 54 | RMD | ResMed Inc. | 27.96B | -1.71% | 780,319 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.60B | -2.34% | 2,076,891 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 24.71B | -3.13% | 1,083,173 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.58B | 1.52% | 2,757,044 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.38B | -1.12% | 725,836 | 3.22B |
| 59 | UTHR | United Therapeutics Corporation | 23.10B | -1.63% | 576,425 | 3.17B |
| 60 | MTD | Mettler-Toledo International Inc. | 22.90B | -2.56% | 141,460 | 4.09B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.56B | -0.37% | 567,576 | 11.28B |
| 62 | LH | Labcorp Holdings Inc. | 22.03B | -0.96% | 633,839 | 14.14B |
| 63 | BNTX | BioNTech SE | 21.79B | -0.40% | 1,033,310 | 3.23B |
| 64 | INCY | Incyte Corporation | 21.06B | 2.09% | 2,654,378 | 5.36B |
| 65 | ROIV | Roivant Sciences Ltd. | 20.43B | -2.20% | 4,267,678 | 8.26M |
| 66 | STE | STERIS plc | 20.31B | -2.25% | 577,110 | 5.94B |
| 67 | INSM | Insmed Incorporated | 19.92B | -7.23% | 5,425,119 | 819.56M |
| 68 | VTRS | Viatris Inc. | 18.36B | -2.65% | 6,600,295 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.25B | -3.65% | 3,214,423 | 2.23B |
| 70 | GH | Guardant Health, Inc. | 17.33B | 0.45% | 1,796,585 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.06B | -1.63% | 1,555,558 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.17B | -2.65% | 1,092,867 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.26B | -2.55% | 876,185 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.41B | 0.19% | 954,759 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.19B | -0.96% | 901,126 | 21.46B |
| 76 | SOLV | Solventum Corporation | 14.02B | -1.84% | 947,147 | 8.26B |
| 77 | MEDP | Medpace Holdings, Inc. | 13.30B | -0.23% | 278,719 | 2.68B |
| 78 | EXEL | Exelixis, Inc. | 13.22B | -0.77% | 3,104,076 | 2.38B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.41% | 2,128,413 | 579.96M |
| 80 | COO | The Cooper Companies, Inc. | 13.20B | -1.36% | 3,013,404 | 4.23B |
| 81 | SNN | Smith & Nephew plc | 13.18B | -1.34% | 720,292 | 6.16B |
| 82 | ASND | Ascendis Pharma A/S | 13.03B | -1.61% | 387,643 | 998.25M |
| 83 | DVA | DaVita Inc. | 12.75B | 0.18% | 633,791 | 13.84B |
| 84 | AXSM | Axsome Therapeutics, Inc. | 12.68B | 0.28% | 741,193 | 708.24M |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.62B | -0.67% | 2,696,329 | 13.65B |
| 86 | PEN | Penumbra, Inc. | 12.56B | -0.54% | 460,373 | 1.45B |
| 87 | ALGN | Align Technology, Inc. | 12.21B | -4.27% | 1,155,293 | 4.10B |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.13B | -1.61% | 1,595,747 | 1.06B |
| 89 | FMS | Fresenius Medical Care AG | 12.05B | -0.31% | 371,994 | 22.32B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.42B | -6.65% | 7,945,668 | 4.89B |
| 91 | RVTY | Revvity, Inc. | 11.30B | -2.73% | 876,237 | 2.90B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.12B | -0.52% | 1,233,797 | 3.58B |
| 93 | ICLR | ICON Public Limited Company | 11.07B | -4.76% | 1,014,520 | 8.25B |
| 94 | GMED | Globus Medical, Inc. | 10.98B | -2.01% | 2,067,678 | 3.10B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.87B | -1.17% | 287,530 | 1.13B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | -3.00% | 2,055,805 | 3.24B |
| 97 | BAX | Baxter International Inc. | 10.49B | 1.40% | 11,722,913 | 11.32B |
| 98 | PODD | Insulet Corporation | 10.44B | -5.58% | 1,477,759 | 2.90B |
| 99 | MOH | Molina Healthcare, Inc. | 10.31B | -2.55% | 1,080,781 | 43.10B |
| 100 | EHC | Encompass Health Corporation | 10.25B | -0.81% | 746,248 | 6.07B |
| 101 | RGC | Regencell Bioscience Holdings Limited | 10.13B | 0.69% | 52,415 | - |
| 102 | SMMT | Summit Therapeutics Inc. | 10.13B | -8.68% | 8,617,129 | - |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.96B | -3.55% | 1,546,381 | 622.01M |
| 104 | NUVL | Nuvalent, Inc. | 9.74B | 0.08% | 6,272,833 | - |
| 105 | MASI | Masimo Corporation | 9.42B | - | - | 1.56B |
| 106 | KRYS | Krystal Biotech, Inc. | 9.21B | 0.86% | 301,892 | 417.30M |
| 107 | CYTK | Cytokinetics, Incorporated | 9.11B | -2.02% | 1,404,867 | 105.82M |
| 108 | HSIC | Henry Schein, Inc. | 8.98B | -1.47% | 1,240,071 | 13.38B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.97B | -1.88% | 586,930 | 4.03B |
| 110 | TEM | Tempus AI, Inc. | 8.88B | 1.35% | 7,191,644 | 1.36B |
| 111 | ENSG | The Ensign Group, Inc. | 8.79B | -2.32% | 1,108,156 | 5.27B |
| 112 | UHS | Universal Health Services, Inc. | 8.77B | -1.21% | 675,860 | 17.76B |
| 113 | OSCR | Oscar Health, Inc. | 8.39B | 2.31% | 7,062,119 | 13.30B |
| 114 | CORT | Corcept Therapeutics Incorporated | 8.39B | 0.81% | 1,494,264 | 769.10M |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.36B | -1.37% | 1,341,872 | 1.51B |
| 116 | BRKR | Bruker Corporation | 8.36B | -4.05% | 1,354,848 | 3.46B |
| 117 | TECH | Bio-Techne Corporation | 8.22B | -3.51% | 2,280,965 | 1.21B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.79B | -2.07% | 363,922 | 2.59B |
| 119 | ABVX | ABIVAX Société Anonyme | 7.74B | -4.57% | 1,362,795 | 5.67M |
| 120 | QGEN | Qiagen N.V. | 7.66B | -1.93% | 2,488,176 | 2.10B |
| 121 | HQY | HealthEquity, Inc. | 7.50B | 0.55% | 663,235 | 1.34B |
| 122 | RGEN | Repligen Corporation | 7.38B | 0.48% | 1,212,153 | 763.34M |
| 123 | ATR | AptarGroup, Inc. | 7.32B | -1.06% | 496,792 | 3.87B |
| 124 | IBRX | ImmunityBio, Inc. | 7.31B | -3.72% | 8,378,606 | 140.98M |
| 125 | ALKS | Alkermes plc | 7.31B | -1.02% | 1,648,102 | 1.56B |
| 126 | GKOS | Glaukos Corporation | 7.19B | -3.05% | 1,542,233 | 551.35M |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 6.80B | -0.09% | 769,970 | 74.06M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 6.71B | -3.86% | 339,360 | 7.46M |
| 129 | TGTX | TG Therapeutics, Inc. | 6.61B | 7.49% | 5,110,582 | 700.35M |
| 130 | AVTR | Avantor, Inc. | 6.59B | -2.62% | 7,300,114 | 6.55B |
| 131 | PCVX | Vaxcyte, Inc. | 6.56B | -3.11% | 1,029,570 | - |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.53B | 0.26% | 651,931 | 1.55B |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.52B | -1.78% | 843,959 | - |
| 134 | LEGN | Legend Biotech Corporation | 6.47B | 4.09% | 1,909,994 | 1.14B |
| 135 | KYMR | Kymera Therapeutics, Inc. | 6.44B | 1.72% | 604,682 | 51.48M |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.43B | -4.14% | 16,718,428 | 2.37B |
| 137 | IMVT | Immunovant, Inc. | 6.40B | -1.36% | 1,493,032 | - |
| 138 | GRFS | Grifols, S.A. | 6.28B | -0.27% | 950,368 | 8.58B |
| 139 | APGE | Apogee Therapeutics, Inc. | 6.20B | -2.68% | 644,329 | - |
| 140 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.15% | 1,780,788 | 15.00M |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.09B | -0.33% | 1,190,858 | 827.11M |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.87B | -2.45% | 851,948 | 217.17M |
| 143 | TFX | Teleflex Incorporated | 5.85B | -2.65% | 517,001 | 2.13B |
| 144 | LQDA | Liquidia Corporation | 5.80B | 1.94% | 2,328,840 | 288.07M |
| 145 | CHE | Chemed Corporation | 5.74B | -2.65% | 225,091 | 2.54B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 5.73B | -1.55% | 471,800 | 569.61M |
| 147 | BLCO | Bausch + Lomb Corporation | 5.44B | -2.49% | 258,970 | 5.21B |
| 148 | PACS | PACS Group, Inc. | 5.43B | -2.47% | 845,259 | 5.43B |
| 149 | BLTE | Belite Bio, Inc | 5.39B | -3.05% | 96,847 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 5.36B | -1.88% | 2,510,057 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.28B | -3.27% | 1,457,699 | - |
| 152 | LGND | Ligand Pharmaceuticals Incorporated | 4.97B | 2.04% | 240,014 | 274.48M |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 4.96B | -2.64% | 1,259,392 | 7.50M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 4.89B | 4.29% | 3,414,098 | 3.05B |
| 155 | CAI | Caris Life Sciences, Inc. | 4.85B | 1.18% | 2,518,805 | 907.29M |
| 156 | CGON | CG Oncology, Inc. | 4.84B | -3.09% | 800,660 | 5.07M |
| 157 | HNGE | Hinge Health, Inc. | 4.80B | -1.15% | 2,897,357 | 646.34M |
| 158 | CRSP | CRISPR Therapeutics AG | 4.77B | -3.96% | 1,403,957 | 4.10M |
| 159 | STVN | Stevanato Group S.p.A. | 4.71B | -4.70% | 471,081 | 1.39B |
| 160 | SHC | Sotera Health Company | 4.64B | -1.57% | 1,924,262 | 1.19B |
| 161 | RDNT | RadNet, Inc. | 4.57B | 3.52% | 836,561 | 2.14B |
| 162 | BLLN | BillionToOne, Inc. | 4.57B | -3.06% | 1,040,518 | 354.54M |
| 163 | TVTX | Travere Therapeutics, Inc. | 4.35B | -3.77% | 1,631,601 | 536.20M |
| 164 | LIVN | LivaNova PLC | 4.31B | 1.57% | 1,383,648 | 1.43B |
| 165 | CELC | Celcuity Inc. | 4.30B | -4.70% | 1,965,205 | - |
| 166 | ALHC | Alignment Healthcare, Inc. | 4.25B | 7.08% | 13,675,352 | 4.26B |
| 167 | TWST | Twist Bioscience Corporation | 4.22B | -3.27% | 1,145,244 | 409.48M |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | -9.64% | 4,485,095 | 1.34M |
| 169 | ERAS | Erasca, Inc. | 4.16B | -0.30% | 2,727,817 | - |
| 170 | TNGX | Tango Therapeutics, Inc. | 4.15B | -9.13% | 9,848,553 | 56.99M |
| 171 | MMED | MiniMed Group, Inc. | 4.13B | -2.71% | 748,621 | 3.10B |
| 172 | MMSI | Merit Medical Systems, Inc. | 4.00B | -0.77% | 732,110 | 1.54B |
| 173 | NVST | Envista Holdings Corporation | 3.92B | -2.16% | 2,640,081 | 2.81B |
| 174 | MANE | Veradermics, Incorporated | 3.88B | -3.05% | 399,525 | - |
| 175 | ORKA | Oruka Therapeutics, Inc. | 3.86B | -4.33% | 1,002,313 | - |
| 176 | VCYT | Veracyte, Inc. | 3.84B | -2.17% | 1,390,845 | 541.74M |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | - | 753,483 | 596.96M |
| 178 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.79B | 1.17% | 462,712 | 754.05M |
| 179 | IRTC | iRhythm Holdings, Inc. | 3.75B | 0.18% | 491,357 | 787.85M |
| 180 | DOCS | Doximity, Inc. | 3.70B | -1.03% | 3,963,730 | 644.86M |
| 181 | TXG | 10x Genomics, Inc. | 3.70B | -4.84% | 2,479,104 | 638.78M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | -2.70% | 931,803 | 1.10B |
| 183 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.63B | -1.63% | 625,284 | 18.07M |
| 184 | WAY | Waystar Holding Corp. | 3.61B | -1.93% | 2,232,729 | 1.16B |
| 185 | HAE | Haemonetics Corporation | 3.58B | 0.11% | 1,006,925 | 1.33B |
| 186 | PBLS | Parabilis Medicines, Inc. | 3.57B | 58.00% | 5,316,701 | - |
| 187 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | -3.35% | 1,345,437 | - |
| 188 | OGN | Organon & Co. | 3.51B | -0.15% | 1,673,650 | 6.16B |
| 189 | ICUI | ICU Medical, Inc. | 3.50B | -1.30% | 240,199 | 2.16B |
| 190 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -3.49% | 861,002 | 22.57M |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.41B | 1.91% | 989,208 | 2.23B |
| 192 | OPCH | Option Care Health, Inc. | 3.36B | 1.28% | 4,669,438 | 5.67B |
| 193 | DNLI | Denali Therapeutics Inc. | 3.27B | -0.87% | 2,483,591 | - |
| 194 | TLX | Telix Pharmaceuticals Limited | 3.22B | 0.32% | 94,822 | 803.79M |
| 195 | VKTX | Viking Therapeutics, Inc. | 3.22B | -5.06% | 2,461,989 | - |
| 196 | BKD | Brookdale Senior Living Inc. | 3.13B | 1.87% | 4,984,274 | 3.00B |
| 197 | ITGR | Integer Holdings Corporation | 3.10B | -2.90% | 284,265 | 1.86B |
| 198 | WRBY | Warby Parker Inc. | 3.07B | 0.81% | 3,871,683 | 890.57M |
| 199 | LFST | LifeStance Health Group, Inc. | 3.05B | 2.35% | 2,129,840 | 1.49B |
| 200 | NHC | National HealthCare Corporation | 3.00B | -0.16% | 153,428 | 1.53B |
| 201 | GPCR | Structure Therapeutics Inc. | 2.95B | 0.68% | 1,093,027 | - |
| 202 | RLAY | Relay Therapeutics, Inc. | 2.94B | -4.26% | 2,520,429 | 10.68M |
| 203 | BEAM | Beam Therapeutics Inc. | 2.94B | -3.22% | 1,215,331 | 164.01M |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.93B | -1.09% | 1,267,565 | - |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 2.91B | 1.93% | 1,411,313 | 415.62M |
| 206 | PRVA | Privia Health Group, Inc. | 2.89B | 3.38% | 1,242,918 | 2.25B |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.78B | -6.43% | 2,249,718 | 236.00M |
| 208 | ADPT | Adaptive Biotechnologies Corporation | 2.73B | -1.67% | 3,005,981 | 295.41M |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 2.66B | 0.33% | 412,612 | 1.46B |
| 210 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -0.35% | 319,936 | 535.08M |
| 211 | SUPN | Supernus Pharmaceuticals, Inc. | 2.62B | -1.25% | 380,057 | 776.83M |
| 212 | TMDX | TransMedics Group, Inc. | 2.58B | 0.65% | 969,485 | 635.89M |
| 213 | CLOV | Clover Health Investments, Corp. | 2.58B | 13.99% | 24,413,099 | 2.21B |
| 214 | IRON | Disc Medicine, Inc. | 2.57B | -1.59% | 271,614 | - |
| 215 | ALMS | Alumis Inc. | 2.56B | 0.25% | 1,184,348 | 8.40M |
| 216 | HTFL | HeartFlow, Inc. | 2.54B | 2.95% | 1,668,796 | 191.42M |
| 217 | DFTX | Definium Therapeutics, Inc. | 2.53B | 1.26% | 2,295,975 | - |
| 218 | GRAL | GRAIL, Inc. | 2.51B | -3.79% | 794,196 | 156.12M |
| 219 | KLRA | Kailera Therapeutics, Inc. | 2.47B | -3.00% | 368,596 | - |
| 220 | IDYA | IDEAYA Biosciences, Inc. | 2.42B | -1.67% | 1,559,394 | 225.27M |
| 221 | ESTA | Establishment Labs Holdings Inc. | 2.34B | -0.45% | 473,350 | 229.58M |
| 222 | PBH | Prestige Consumer Healthcare Inc. | 2.33B | 0.97% | 586,729 | 1.09B |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.30B | -0.84% | 490,422 | 865.00K |
| 224 | VERA | Vera Therapeutics, Inc. | 2.27B | -0.60% | 697,197 | - |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.26B | 0.79% | 877,775 | 670.00M |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.25B | 2.46% | 1,293,455 | - |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.20B | -6.24% | 1,801,205 | 3.37B |
| 228 | AXGN | Axogen, Inc. | 2.20B | -3.57% | 1,240,233 | 238.11M |
| 229 | PHVS | Pharvaris N.V. | 2.20B | -0.28% | 183,661 | - |
| 230 | LMAT | LeMaitre Vascular, Inc. | 2.11B | -4.24% | 284,066 | 256.28M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.08B | -1.68% | 3,652,264 | 885.72M |
| 232 | SEM | Select Medical Holdings Corporation | 2.06B | -0.18% | 651,870 | 5.52B |
| 233 | IMNM | Immunome, Inc. | 2.06B | -1.25% | 1,139,967 | 4.02M |
| 234 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 4.05% | 1,674,972 | 899.11M |
| 235 | PGNY | Progyny, Inc. | 2.03B | 0.23% | 1,121,885 | 1.29B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -0.76% | 993,002 | 298.30M |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.01B | -4.11% | 3,234,486 | 3.68B |
| 238 | NEOG | Neogen Corporation | 2.00B | -1.29% | 1,949,575 | 870.56M |
| 239 | ADMA | ADMA Biologics, Inc. | 1.97B | 4.43% | 3,337,489 | 509.86M |
| 240 | KOD | Kodiak Sciences Inc. | 1.96B | 1.13% | 677,481 | - |
| 241 | MLYS | Mineralys Therapeutics, Inc. | 1.96B | -1.74% | 1,048,791 | - |
| 242 | ZLAB | Zai Lab Limited | 1.94B | 3.75% | 1,171,092 | 453.28M |
| 243 | HCM | HUTCHMED (China) Limited | 1.93B | 2.40% | 29,444 | 548.51M |
| 244 | NVCR | NovoCure Limited | 1.93B | -3.42% | 736,056 | 674.41M |
| 245 | ASTH | Astrana Health, Inc. | 1.93B | 1.49% | 903,711 | 3.53B |
| 246 | BHC | Bausch Health Companies Inc. | 1.92B | -0.39% | 1,930,764 | 10.53B |
| 247 | NKTR | Nektar Therapeutics | 1.92B | 0.98% | 872,564 | 55.63M |
| 248 | OCUL | Ocular Therapeutix, Inc. | 1.91B | 3.19% | 2,664,686 | 52.04M |
| 249 | VCEL | Vericel Corporation | 1.91B | 1.08% | 617,750 | 292.09M |
| 250 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -1.40% | 931,509 | - |
| 251 | MD | Pediatrix Medical Group, Inc. | 1.89B | -0.42% | 719,986 | 1.93B |
| 252 | LKFT | Lakefront Biotherapeutics NV | 1.87B | 1.17% | 291,518 | 1.20B |
| 253 | SGRY | Surgery Partners, Inc. | 1.84B | 1.72% | 930,227 | 3.34B |
| 254 | MESO | Mesoblast Limited | 1.83B | -3.36% | 99,339 | 65.38M |
| 255 | UFPT | UFP Technologies, Inc. | 1.80B | 0.62% | 220,040 | 608.85M |
| 256 | STOK | Stoke Therapeutics, Inc. | 1.78B | -2.91% | 534,006 | 32.08M |
| 257 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -3.31% | 1,417,452 | 70.92M |
| 258 | OMCL | Omnicell, Inc. | 1.74B | -6.17% | 791,836 | 1.23B |
| 259 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 0.71% | 260,474 | 923.71M |
| 260 | PLSE | Pulse Biosciences, Inc. | 1.73B | -3.03% | 256,813 | 751.00K |
| 261 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | 2.67% | 996,939 | 66.05M |
| 262 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -5.35% | 3,316,770 | 66.09M |
| 263 | ADUS | Addus HomeCare Corporation | 1.70B | 0.56% | 154,320 | 1.45B |
| 264 | INVA | Innoviva, Inc. | 1.70B | 2.04% | 727,520 | 420.69M |
| 265 | AGL | agilon health, inc. | 1.70B | -0.45% | 295,798 | 5.82B |
| 266 | QURE | uniQure N.V. | 1.69B | 1.36% | 1,119,847 | 18.09M |
| 267 | IOVA | Iovance Biotherapeutics, Inc. | 1.69B | -2.58% | 8,858,613 | 285.61M |
| 268 | GENB | Generate Biomedicines, Inc. | 1.69B | -0.23% | 381,330 | 30.30M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -1.80% | 344,562 | 20.00M |
| 270 | SNDA | Sonida Senior Living, Inc. | 1.67B | 0.53% | 518,576 | 367.34M |
| 271 | ZYME | Zymeworks Inc. | 1.67B | -1.72% | 620,733 | 81.26M |
| 272 | BHVN | Biohaven Ltd. | 1.67B | -0.18% | 3,935,881 | - |
| 273 | NBTX | Nanobiotix S.A. | 1.66B | -2.55% | 77,389 | 38.27M |
| 274 | PRCT | PROCEPT BioRobotics Corporation | 1.66B | 1.08% | 848,185 | 322.02M |
| 275 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | -5.59% | 17,518,257 | 66.41M |
| 276 | WGS | GeneDx Holdings Corp. | 1.61B | -3.57% | 1,015,273 | 442.68M |
| 277 | AAPG | Ascentage Pharma Group International | 1.61B | 1.58% | 1,616 | 82.08M |
| 278 | SRPT | Sarepta Therapeutics, Inc. | 1.60B | -4.91% | 2,318,184 | 2.18B |
| 279 | NUVB | Nuvation Bio Inc. | 1.59B | -7.10% | 6,156,948 | 143.05M |
| 280 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -2.17% | 2,130,825 | 71.78M |
| 281 | SNDX | Syndax Pharmaceuticals, Inc. | 1.56B | -0.62% | 1,395,263 | 217.17M |
| 282 | ABCL | AbCellera Biologics Inc. | 1.55B | -3.96% | 3,515,150 | 79.21M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.55B | 0.75% | 2,180,736 | 7.47M |
| 284 | FTRE | Fortrea Holdings Inc. | 1.55B | -3.20% | 1,051,928 | 2.71B |
| 285 | PRGO | Perrigo Company plc | 1.55B | -0.09% | 5,610,849 | 4.18B |
| 286 | SION | Sionna Therapeutics, Inc. | 1.54B | 0.95% | 316,927 | - |
| 287 | ANAB | AnaptysBio, Inc. | 1.52B | 0.91% | 445,357 | 232.39M |
| 288 | TYRA | Tyra Biosciences, Inc. | 1.51B | -2.00% | 628,730 | - |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.50B | 0.29% | 1,861,981 | 2.52B |
| 290 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | -0.66% | 684,291 | -665.00K |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.49B | 6.86% | 187,759 | 87.16M |
| 292 | CMPS | COMPASS Pathways plc | 1.49B | -2.04% | 2,158,982 | - |
| 293 | MBX | MBX Biosciences, Inc. | 1.48B | 3.75% | 971,306 | - |
| 294 | NEO | NeoGenomics, Inc. | 1.47B | -1.40% | 2,220,404 | 745.97M |
| 295 | CAPR | Capricor Therapeutics, Inc. | 1.47B | -2.61% | 1,334,723 | 11.13M |
| 296 | PVLA | Palvella Therapeutics, Inc. | 1.46B | -2.19% | 359,267 | - |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.46B | - | 762,008 | 1.85B |
| 298 | STAA | STAAR Surgical Company | 1.46B | -1.81% | 377,698 | 290.38M |
| 299 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | 0.04% | 1,836,217 | 114.48M |
| 300 | AVBP | ArriVent BioPharma, Inc. | 1.42B | -0.08% | 373,847 | - |
| 301 | IMCR | Immunocore Holdings plc | 1.42B | -2.17% | 318,095 | 412.81M |
| 302 | BFLY | Butterfly Network, Inc. | 1.41B | 5.27% | 7,638,575 | 102.92M |
| 303 | NVAX | Novavax, Inc. | 1.41B | -1.27% | 3,088,705 | 596.34M |
| 304 | GHRS | GH Research PLC | 1.40B | 0.05% | 140,664 | - |
| 305 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -0.54% | 873,050 | 42.95M |
| 306 | ATRC | AtriCure, Inc. | 1.39B | 0.73% | 703,862 | 552.16M |
| 307 | ATAI | AtaiBeckley Inc. | 1.39B | -2.83% | 3,076,590 | 3.49M |
| 308 | VIR | Vir Biotechnology, Inc. | 1.39B | -3.06% | 1,707,654 | 65.50M |
| 309 | PGEN | Precigen, Inc. | 1.39B | 4.85% | 3,880,292 | 31.60M |
| 310 | ARDX | Ardelyx, Inc. | 1.39B | 0.18% | 2,934,540 | 427.68M |
| 311 | SEPN | Septerna, Inc. | 1.37B | -1.77% | 171,876 | 72.26M |
| 312 | URGN | UroGen Pharma Ltd. | 1.36B | -0.64% | 618,488 | 140.49M |
| 313 | HROW | Harrow, Inc. | 1.34B | 7.29% | 1,279,870 | 268.68M |
| 314 | ARDT | Ardent Health, Inc. | 1.34B | -0.96% | 514,610 | 6.43B |
| 315 | SLS | SELLAS Life Sciences Group, Inc. | 1.33B | -6.90% | 6,262,991 | - |
| 316 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -4.53% | 692,028 | 1.64B |
| 317 | BCAX | Bicara Therapeutics Inc. | 1.33B | -1.61% | 667,012 | - |
| 318 | AHCO | AdaptHealth Corp. | 1.32B | 1.22% | 840,815 | 3.29B |
| 319 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 0.42% | 398,986 | 1.30M |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.31B | -0.39% | 2,704,674 | 204.73M |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.31B | -1.13% | 746,808 | 20.00M |
| 322 | BLFS | BioLife Solutions, Inc. | 1.30B | -3.23% | 433,362 | 101.66M |
| 323 | ALVO | Alvotech | 1.29B | -0.48% | 617,617 | 562.04M |
| 324 | SVRA | Savara Inc. | 1.29B | 3.25% | 1,516,586 | - |
| 325 | MLTX | MoonLake Immunotherapeutics | 1.29B | -1.74% | 694,595 | - |
| 326 | TDOC | Teladoc Health, Inc. | 1.27B | 1.44% | 3,444,767 | 2.51B |
| 327 | PAHC | Phibro Animal Health Corporation | 1.26B | -4.50% | 356,289 | 1.50B |
| 328 | ENOV | Enovis Corporation | 1.26B | -8.31% | 1,514,955 | 2.28B |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.26B | -5.02% | 184,014 | - |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.25B | -1.57% | 1,562,858 | 787.08M |
| 331 | DMRA | Damora Therapeutics, Inc. | 1.24B | -3.84% | 531,780 | - |
| 332 | IRMD | IRADIMED CORPORATION | 1.23B | -0.37% | 153,648 | 86.28M |
| 333 | AHG | Akso Health Group | 1.23B | 2.88% | 609 | 14.84M |
| 334 | INSP | Inspire Medical Systems, Inc. | 1.22B | 0.17% | 764,874 | 915.25M |
| 335 | IMTX | Immatics N.V. | 1.21B | -3.17% | 360,831 | 43.00M |
| 336 | CDNA | CareDx, Inc. | 1.21B | 3.12% | 757,001 | 412.82M |
| 337 | AVLN | Avalyn Pharma Inc. | 1.19B | -0.49% | 342,826 | - |
| 338 | AVNS | Avanos Medical, Inc. | 1.17B | -0.20% | 629,211 | 715.90M |
| 339 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | 3.23% | 2,181,073 | 314.85M |
| 340 | AMN | AMN Healthcare Services, Inc. | 1.14B | -3.13% | 779,660 | 3.42B |
| 341 | KMTS | Kestra Medical Technologies, Ltd. | 1.14B | -2.36% | 261,709 | 83.72M |
| 342 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | -5.17% | 230,969 | - |
| 343 | ZBIO | Zenas BioPharma, Inc. | 1.13B | -2.82% | 432,797 | 10.00M |
| 344 | INNV | InnovAge Holding Corp. | 1.13B | 8.19% | 384,159 | 949.17M |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | 1.16% | 374,980 | 796.33M |
| 346 | PNTG | The Pennant Group, Inc. | 1.12B | -1.43% | 167,608 | 1.02B |
| 347 | MNKD | MannKind Corporation | 1.12B | 1.68% | 3,616,515 | 360.78M |
| 348 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | -7.84% | 2,905,151 | 1.03B |
| 349 | CNMD | CONMED Corporation | 1.09B | -1.63% | 563,711 | 1.37B |
| 350 | WVE | Wave Life Sciences Ltd. | 1.09B | -2.08% | 2,907,137 | 71.80M |
| 351 | OPK | OPKO Health, Inc. | 1.09B | - | 2,215,687 | 581.12M |
| 352 | SDGR | Schrödinger, Inc. | 1.06B | -2.55% | 747,929 | 254.91M |
| 353 | CRON | Cronos Group Inc. | 1.05B | -1.79% | 757,627 | 159.54M |
| 354 | EYPT | EyePoint, Inc. | 1.03B | 4.76% | 1,161,516 | 7.61M |
| 355 | AZTA | Azenta, Inc. | 1.03B | -1.50% | 998,023 | 596.48M |
| 356 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.69% | 123,963 | 8.28M |
| 357 | OMDA | Omada Health, Inc. | 1.02B | -6.66% | 1,817,954 | 283.30M |
| 358 | PSNL | Personalis, Inc. | 1.01B | -1.44% | 1,744,622 | 64.52M |
| 359 | ABSI | Absci Corporation | 994.67M | -6.59% | 4,948,339 | 1.84M |
| 360 | AORT | Artivion, Inc. | 993.68M | -1.96% | 799,675 | 458.69M |
| 361 | USPH | U.S. Physical Therapy, Inc. | 956.20M | 1.67% | 222,611 | 787.69M |
| 362 | EVO | Evotec SE | 943.07M | -5.09% | 52,009 | 859.03M |
| 363 | DBVT | DBV Technologies S.A. | 942.28M | 0.12% | 297,777 | 5.74M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 938.45M | -0.09% | 1,506,802 | - |
| 365 | PCRX | Pacira BioSciences, Inc. | 921.53M | 0.90% | 275,901 | 734.86M |
| 366 | QDEL | QuidelOrtho Corporation | 920.58M | -3.16% | 2,773,119 | 2.66B |
| 367 | SPRY | ARS Pharmaceuticals, Inc. | 919.55M | -1.75% | 1,481,326 | 98.99M |
| 368 | NUTX | Nutex Health Inc. | 913.70M | -1.94% | 207,219 | 879.95M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 907.84M | -3.06% | 156,156 | - |
| 370 | JBIO | Jade Biosciences, Inc. | 905.83M | 0.26% | 1,375,102 | - |
| 371 | AMPH | Amphastar Pharmaceuticals, Inc. | 894.42M | 0.62% | 405,165 | 720.53M |
| 372 | AVR | Anteris Technologies Global Corp. | 891.95M | 0.32% | 1,027,383 | 1.85M |
| 373 | PHAR | Pharming Group N.V. | 882.51M | -2.46% | 3,864 | 369.49M |
| 374 | XNCR | Xencor, Inc. | 877.10M | -0.50% | 650,972 | 97.36M |
| 375 | TALK | Talkspace, Inc. | 872.74M | - | 1,817,814 | 238.37M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 868.57M | 4.51% | 808,415 | 1.03B |
| 377 | GDRX | GoodRx Holdings, Inc. | 867.01M | -3.40% | 1,121,392 | 787.89M |
| 378 | OLMA | Olema Pharmaceuticals, Inc. | 857.75M | -6.03% | 1,788,980 | - |
| 379 | INMD | InMode Ltd. | 853.44M | -0.66% | 487,914 | 374.64M |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 847.79M | 1.38% | 265,560 | 86.93M |
| 381 | MGTX | MeiraGTx Holdings plc | 846.45M | -0.76% | 437,882 | 79.76M |
| 382 | TBPH | Theravance Biopharma, Inc. | 843.92M | -0.73% | 266,480 | 109.78M |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | - | 1,207,300 | 69.64M |
| 384 | DRTS | Alpha Tau Medical Ltd. | 833.23M | 0.54% | 380,296 | - |
| 385 | LBRX | LB Pharmaceuticals Inc | 814.13M | -3.01% | 192,268 | - |
| 386 | ABUS | Arbutus Biopharma Corporation | 813.86M | -3.06% | 1,602,450 | 191.45M |
| 387 | ESPR | Esperion Therapeutics, Inc. | 808.34M | - | 7,085,046 | 418.24M |
| 388 | CERT | Certara, Inc. | 805.82M | - | 3,200,953 | 419.75M |
| 389 | JANX | Janux Therapeutics, Inc. | 801.94M | -3.45% | 932,026 | 13.73M |
| 390 | ZVRA | Zevra Therapeutics, Inc. | 798.05M | -1.17% | 2,419,117 | 122.29M |
| 391 | SANA | Sana Biotechnology, Inc. | 784.78M | - | 2,679,628 | - |
| 392 | ORIC | ORIC Pharmaceuticals, Inc. | 780.52M | -5.75% | 2,083,908 | - |
| 393 | PHAT | Phathom Pharmaceuticals, Inc. | 780.00M | - | 825,977 | 204.89M |
| 394 | IVA | Inventiva S.A. | 779.95M | -4.79% | 645,052 | 7.94M |
| 395 | ANNX | Annexon, Inc. | 773.34M | -9.23% | 2,627,034 | - |
| 396 | KURA | Kura Oncology, Inc. | 770.56M | -1.48% | 1,816,006 | 71.64M |
| 397 | HSTM | HealthStream, Inc. | 768.94M | 1.23% | 165,375 | 311.78M |
| 398 | ODTX | Odyssey Therapeutics, Inc. | 764.22M | -5.21% | 421,346 | 2.98M |
| 399 | BVS | Bioventus Inc. | 755.99M | -1.63% | 400,695 | 576.30M |
| 400 | CGEM | Cullinan Therapeutics, Inc. | 740.57M | -8.57% | 2,080,091 | - |
| 401 | OMER | Omeros Corporation | 738.23M | 2.31% | 1,371,887 | 9.89M |
| 402 | EVMN | Evommune, Inc. | 738.02M | - | 562,876 | 10.00M |
| 403 | NNNN | Anbio Biotechnology | 726.40M | 2.41% | 20,183 | 8.65M |
| 404 | GMRS | GMR Solutions Inc. | 711.87M | 13.43% | 1,158,154 | 5.83B |
| 405 | GERN | Geron Corporation | 705.67M | -1.79% | 13,200,820 | 196.12M |
| 406 | SSII | SS Innovations International, Inc. | 704.46M | -1.12% | 30,805 | 48.47M |
| 407 | VOR | Vor Biopharma Inc. | 704.42M | -2.11% | 770,765 | - |
| 408 | REPL | Replimune Group, Inc. | 699.39M | -8.33% | 3,369,864 | - |
| 409 | CBLL | CeriBell, Inc. | 697.39M | -0.65% | 251,480 | 95.07M |
| 410 | ANRO | Alto Neuroscience, Inc. | 690.65M | -6.95% | 346,965 | - |
| 411 | AVTX | Avalo Therapeutics, Inc. | 688.61M | 1.55% | 1,632,495 | 59.00K |
| 412 | BIOA | BioAge Labs, Inc. | 688.13M | -2.03% | 335,254 | 10.32M |
| 413 | CRMD | CorMedix Inc. | 688.02M | 1.39% | 1,172,103 | 400.05M |
| 414 | SIBN | SI-BONE, Inc. | 681.20M | -1.09% | 356,056 | 206.22M |
| 415 | AURA | Aura Biosciences, Inc. | 675.03M | -3.62% | 676,686 | - |
| 416 | RLMD | Relmada Therapeutics, Inc. | 669.20M | 1.75% | 1,456,356 | - |
| 417 | DSGN | Design Therapeutics, Inc. | 665.79M | 1.04% | 614,656 | - |
| 418 | OCS | Oculis Holding AG | 662.46M | -0.09% | 644,688 | 1.40M |
| 419 | SLDB | Solid Biosciences Inc. | 650.75M | 0.61% | 1,134,175 | - |
| 420 | CSTL | Castle Biosciences, Inc. | 639.36M | - | 245,606 | 339.92M |
| 421 | CTMX | CytomX Therapeutics, Inc. | 633.52M | -2.35% | 1,602,251 | 35.54M |
| 422 | TENX | Tenax Therapeutics, Inc. | 621.17M | -1.68% | 370,105 | - |
| 423 | DRUG | Bright Minds Biosciences Inc. | 614.69M | -9.35% | 708,274 | - |
| 424 | ALLO | Allogene Therapeutics, Inc. | 614.38M | -2.20% | 7,408,394 | 22.00K |
| 425 | CADL | Candel Therapeutics, Inc. | 611.81M | -3.69% | 1,478,430 | - |
| 426 | BBNX | Beta Bionics, Inc. | 611.39M | -4.66% | 712,516 | 110.24M |
| 427 | SGP | SpyGlass Pharma, Inc. | 603.68M | -0.71% | 84,426 | - |
| 428 | TLRY | Tilray Brands, Inc. | 598.80M | -2.90% | 3,135,455 | 858.28M |
| 429 | ACHV | Achieve Life Sciences, Inc. | 590.29M | 2.68% | 1,266,024 | - |
| 430 | TCMD | Tactile Systems Technology, Inc. | 585.90M | -1.39% | 224,664 | 343.52M |
| 431 | CBIO | Crescent Biopharma, Inc. | 583.83M | -2.39% | 158,391 | 11.88M |
| 432 | ACRS | Aclaris Therapeutics, Inc. | 574.02M | -4.42% | 1,224,389 | 8.37M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 572.93M | 2.82% | 365,430 | - |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 571.90M | 0.62% | 209,962 | 299.77M |
| 435 | IMMX | Immix Biopharma, Inc. | 570.89M | 2.12% | 1,107,540 | - |
| 436 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 570.36M | -1.93% | 308,059 | - |
| 437 | BWAY | BrainsWay Ltd. | 568.40M | -1.94% | 129,316 | 56.22M |
| 438 | PHR | Phreesia, Inc. | 564.96M | -1.61% | 1,067,887 | 495.59M |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 551.45M | 4.04% | 1,554,082 | 361.51M |
| 440 | GYRE | Gyre Therapeutics, Inc. | 544.58M | -2.77% | 71,007 | 117.05M |
| 441 | MDXG | MiMedx Group, Inc. | 542.16M | -1.89% | 967,996 | 389.42M |
| 442 | FLGT | Fulgent Genetics, Inc. | 537.62M | 2.32% | 327,585 | 320.35M |
| 443 | NPCE | NeuroPace, Inc. | 535.61M | -1.57% | 87,480 | 99.53M |
| 444 | TECX | Tectonic Therapeutic, Inc. | 531.73M | -1.33% | 101,741 | - |
| 445 | XOMA | XOMA Royalty Corporation | 524.03M | -0.39% | 125,243 | 48.56M |
| 446 | CTKB | Cytek Biosciences, Inc. | 523.03M | -1.94% | 1,068,930 | 204.17M |
| 447 | DNA | Ginkgo Bioworks Holdings, Inc. | 518.68M | -3.76% | 854,617 | 151.40M |
| 448 | CLYM | Climb Bio, Inc. | 515.90M | -3.01% | 587,741 | - |
| 449 | AGMB | AgomAb Therapeutics NV | 513.66M | 6.43% | 97,030 | - |
| 450 | CERS | Cerus Corporation | 512.94M | -0.78% | 1,840,925 | 216.56M |
| 451 | ANGO | AngioDynamics, Inc. | 511.86M | -0.49% | 299,781 | 313.73M |
| 452 | ALT | Altimmune, Inc. | 507.58M | -1.88% | 2,540,088 | 36.00K |
| 453 | CTEV | Claritev Corporation | 507.00M | 4.90% | 82,096 | 978.76M |
| 454 | PROK | ProKidney Corp. | 504.44M | - | 669,227 | 889.00K |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 456 | EVH | Evolent Health, Inc. | 502.79M | -5.30% | 1,900,756 | 1.89B |
| 457 | AQST | Aquestive Therapeutics, Inc. | 500.55M | - | 1,576,505 | 50.27M |
| 458 | CABA | Cabaletta Bio, Inc. | 495.69M | -5.59% | 2,895,092 | - |
| 459 | VALN | Valneva SE | 492.14M | -0.94% | 16,121 | 180.25M |
| 460 | PRME | Prime Medicine, Inc. | 489.47M | -5.90% | 2,200,388 | 4.03M |
| 461 | NRC | NRC Health | 479.58M | 7.75% | 759,757 | 138.64M |
| 462 | SRTA | Strata Critical Medical, Inc. | 474.17M | -2.32% | 1,306,879 | 228.58M |
| 463 | KIDS | OrthoPediatrics Corp. | 474.14M | -0.16% | 95,580 | 243.30M |
| 464 | TOI | The Oncology Institute, Inc. | 467.92M | -5.65% | 1,543,025 | 545.76M |
| 465 | KYTX | Kyverna Therapeutics, Inc. | 463.66M | -2.42% | 527,553 | - |
| 466 | FDMT | 4D Molecular Therapeutics, Inc. | 455.85M | -5.53% | 622,632 | 88.24M |
| 467 | EIKN | Eikon Therapeutics, Inc. | 452.60M | -4.68% | 136,248 | - |
| 468 | ARVN | Arvinas, Inc. | 450.36M | -3.19% | 680,243 | 89.40M |
| 469 | WEAV | Weave Communications, Inc. | 443.98M | - | 510,354 | 248.72M |
| 470 | VREX | Varex Imaging Corporation | 443.38M | -0.94% | 267,821 | 857.50M |
| 471 | NGNE | Neurogene Inc. | 442.61M | -2.78% | 237,443 | 925.00K |
| 472 | EOLS | Evolus, Inc. | 442.54M | 0.30% | 670,705 | 301.79M |
| 473 | ASMB | Assembly Biosciences, Inc. | 440.14M | -2.24% | 195,482 | 71.10M |
| 474 | STRO | Sutro Biopharma, Inc. | 432.65M | 1.24% | 196,988 | 99.61M |
| 475 | MOBI | Mobia Medical, Inc. | 428.12M | 1.73% | 197,329 | 32.04M |
| 476 | CCCC | C4 Therapeutics, Inc. | 427.90M | 8.10% | 2,276,908 | 34.86M |
| 477 | OVID | Ovid Therapeutics Inc. | 425.54M | -5.79% | 1,606,481 | 7.12M |
| 478 | PACB | Pacific Biosciences of California, Inc. | 425.52M | - | 4,316,439 | 160.03M |
| 479 | EBS | Emergent BioSolutions Inc. | 425.15M | 3.65% | 780,381 | 676.80M |
| 480 | ANL | Adlai Nortye Ltd. | 422.60M | -2.54% | 69,556 | 5.00M |
| 481 | CTNM | Contineum Therapeutics, Inc. | 422.47M | -1.14% | 114,480 | - |
| 482 | MYGN | Myriad Genetics, Inc. | 418.41M | -2.42% | 1,444,921 | 829.00M |
| 483 | KMDA | Kamada Ltd. | 417.22M | -0.41% | 30,449 | 181.68M |
| 484 | PRTA | Prothena Corporation plc | 414.11M | -6.61% | 380,463 | 57.94M |
| 485 | CLPT | ClearPoint Neuro, Inc. | 412.36M | 1.18% | 398,163 | 40.61M |
| 486 | FBRX | Forte Biosciences, Inc. | 411.01M | -1.06% | 217,394 | - |
| 487 | CCRN | Cross Country Healthcare, Inc. | 408.69M | - | 249,680 | 1.00B |
| 488 | OCGN | Ocugen, Inc. | 402.84M | -4.03% | 5,748,457 | 4.47M |
| 489 | CYH | Community Health Systems, Inc. | 402.30M | 3.48% | 1,334,489 | 12.29B |
| 490 | SGMT | Sagimet Biosciences Inc. | 401.39M | -0.31% | 718,807 | - |
| 491 | MNPR | Monopar Therapeutics Inc. | 400.12M | -1.48% | 81,012 | - |
| 492 | RZLT | Rezolute, Inc. | 398.02M | -2.31% | 1,229,198 | - |
| 493 | AUTL | Autolus Therapeutics plc | 395.22M | 1.71% | 888,673 | 92.62M |
| 494 | PRLD | Prelude Therapeutics Incorporated | 393.24M | 0.63% | 192,717 | 16.72M |
| 495 | OFIX | Orthofix Medical Inc. | 393.10M | -1.47% | 266,434 | 825.37M |
| 496 | CGC | Canopy Growth Corporation | 390.96M | -0.98% | 3,418,529 | 203.04M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 390.48M | -0.67% | 219,040 | - |
| 498 | VMD | Viemed Healthcare, Inc. | 388.16M | 2.07% | 166,462 | 286.57M |
| 499 | DCTH | Delcath Systems, Inc. | 386.30M | -4.28% | 537,054 | 90.44M |
| 500 | TBRG | TruBridge, Inc. | 385.98M | 0.27% | 257,218 | 345.90M |